CLINICAL_TRIALS
trial_result
· 2012-11-09
Clinical Trial Update: Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD) [Phase 2]
Summary
A Phase 2 study evaluating esophageal hypersensitivity in patients with gastroesophageal reflux disease (GERD) completed, with results posted in November 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Sensitivity in Esophagus | Phase 2 | Status: COMPLETED | Results posted: 2012-11-09